109 Results for "

CK2,

" in MedChemExpress (MCE) Product Catalog:
Products (109)

109 Results for "CK2," in MCE Product Catalog:

Cat. No.: HY-B0183S
Ellagic acid- 13C12 is 13 C-labeled Ellagic acid (HY-B0183). Ellagic acid is a natural antioxidant and acts as a potent and ATP-competitive inhibitor of CK2 and SHP2, with an IC50 of 40 nM and a Ki of 20 nM [2].
loading...
    loading...
Cat. No.: HY-174350
Target:  

Casein Kinase SARS-CoV

Research Areas:  

Infection

CK2-IN-15 (Compound Biv5) is a selective and potent bivalent protein kinase CK2 inhibitor with an IC50 value of 51 pM. CK2-IN-15 significantly reduces the replication of SARS-CoV-2 in HEK-ACE2-TMPRSS2 and Vero cells, and also reduces viral replication in an ex vivo model of human nasal epithelial cells. CK2-IN-15 is promising for research of β-coronavirus infection-related diseases .
loading...
    loading...
Cat. No.: HY-P11496
CAS No.: 154444-98-1
Target:  

Casein Kinase

Research Areas:  

Neurological Disease

CK2 Substrate peptide (Compound RRRADDSDDDDD) is a specific CK2 peptide substrate with Km of 13 μM. CK2 Substrate peptide can be used for the research of neurological disease, such as Alzheimer's Disease .
loading...
    loading...
Cat. No.: HY-143461
CAS No.: 2979847-14-6
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2 inhibitor 3 is a potent CK2 inhibitor with IC50 value of 280 nM. CK2 inhibitor 3 inhibits endocellular CK2, significantly affects viability of tumour cells and shows remarkable selectivity on a panel of 320 kinases .
loading...
    loading...
Cat. No.: HY-169629
CAS No.: 474263-21-3
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2 inhibitor 4 (compound 5b) is a protein kinase CK2 inhibitor with IC50 of 3.8 μM. CK2 inhibitor 4 can be used in tumor research .
loading...
    loading...
Cat. No.: HY-178980
CAS No.: 2830619-57-1
Target:  

Casein Kinase

Research Areas:  

Cancer

APL-5125 (Compound 61f) is a potent, selective and orally active ATP-competitive CK2α inhibitor with an IC50 of 0.348 nM and a Ki of 0.095 nM. APL-5125 binds to CK2α in a bivalent manner, simultaneously interacting with the ATP-binding site and the αD pocket. APL-5125 exhibits antitumor activity and can be used for the research of cancer, such as colon cancer .
loading...
    loading...
Cat. No.: HY-50855R
CAS No.: 1009820-21-6
Synonyms: CX-4945 (Standard)
Research Areas:  

Cancer

Silmitasertib (Standard) is the analytical standard of Silmitasertib. This product is intended for research and analytical applications. Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'.
loading...
    loading...
Cat. No.: HY-W042648
CAS No.: 577779-57-8
Target:  

Casein Kinase

Research Areas:  

Others

4,5,6,7-Tetrabromobenzimidazole is a selective and ATP competitive CK2 (casein kinase 2) inhibitor .
loading...
    loading...
Cat. No.: HY-B0183R
CAS No.: 476-66-4
Ellagic acid (Standard) is the analytical standard of Ellagic acid. This product is intended for research and analytical applications. Ellagic acid is a natural antioxidant, and acts as a potent and ATP-competitive inhibitor of CK2 and SHP2, with an IC50 of 40 nM and a Ki of 20 nM.
loading...
    loading...
Cat. No.: HY-123853
CAS No.: 2101206-81-7
Target:  

Casein Kinase

Research Areas:  

Cancer

CAM4066 is a potent CK2α inhibitor, with an IC50 value of 300 nM. CAM4066 exhibits high selectivity, with IC50 values of 22.35, 43.55, and > 50 μM for HIPK3, DAPK3, and CLK2, respectively. CAM4066 shows no cell activity. CAM4066 can be used for the development of highly potent CK2 inhibitors .
loading...
    loading...
Cat. No.: HY-153788
CAS No.: 2825012-70-0
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2-IN-7 (compound 2) is an inhibitor of casein kinase 2 (CK2). CK2-IN-7 shows synergistic effect with structurally distinct CK2 chemical probe: SGC-CK2-1, against cancer .
loading...
    loading...
Cat. No.: HY-169985
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2-IN-13 (compound 12c) is a potent inhibitor of CK2, with the IC50 of 5.8 nM. CK2-IN-13 plays an important role in cancer research .
loading...
    loading...
Cat. No.: HY-121792
CAS No.: 51726-83-1
Target:  

Casein Kinase

Research Areas:  

Others

CK2-IN-1 is a CK2 inhibitor, with an IC50 of 150 nM .
loading...
    loading...
Cat. No.: HY-151382
CAS No.: 2969205-85-2
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2-IN-3 is a selective and potent CK2 inhibitor (Kd: 12 nM), with IC50 values of 1.51 μM (CK2α) and 7.64 μM (CK2α’). CK2-IN-3 can be used in the research of cancers .
loading...
    loading...
Cat. No.: HY-12570
CAS No.: 1461658-58-1
Target:  

Casein Kinase Wnt

Research Areas:  

Cancer

CK2-IN-9 is a potent and selective inhibitor of CK2 kinase with an IC50 of 3 nM. CK2-IN-9 reduces Wnt reporter activity with an IC50 of 75 nM. CK2-IN-9 has low exposure (AUC=0.36 μM/h) and high clearance (CL=65 mL/min/kg) properties in rat .
loading...
    loading...
Cat. No.: HY-158370
CAS No.: 2938991-22-9
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2-IN-11 (32) is an allosteric CK2 inhibitor, with high selectivity for CK2 with IC50 values of 19.3 nM and 15.6 nM for the CK2α2β2 and the CK2α′2β2 isoforms, respectively .
loading...
    loading...
Cat. No.: HY-155987
CAS No.: 442571-27-9
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2-IN-8 (compound 5c) is a CK2 inhibitor with IC50 >33 μM .
loading...
    loading...
Cat. No.: HY-118403
CAS No.: 300675-28-9
Target:  

Casein Kinase

CK2-IN-12 (Compound 39) is an inhibitor for protein kinase CK2 with an IC50 of 0.8 μM .
loading...
    loading...
Cat. No.: HY-50733
CAS No.: 1009821-06-0
Research Areas:  

Cancer

CX-5011 free base is a potent CK2 inhibitor. CX-5011 free base also is a Rac-1 activator. CX-5011 free base induces methuosis and promotes macropinocytosis. CX-5011 free base induces apoptosis. CX-5011 free base decreases the expression of rpS6 phosphorylation [2].
loading...
    loading...
Cat. No.: HY-168517
Research Areas:  

Cancer

PIM-1/CK2-IN-2 (compound 3aA) is a PIM-1/CK2 inhibitor. PIM-1/CK2-IN-2 can induce the mitochondrial apoptotic pathway in CCRF-CEM cells. PIM-1/CK2-IN-2 can be used in cancer research .
loading...
    loading...